12. Internation Symposium on Pharmaceutical Sciences (ISOPS 12), Ankara, Türkiye, 26 - 29 Haziran 2018, ss.329-330, (Tam Metin Bildiri)
Nanoparticles are one of the multiparticulate delivery systems and are prepared to improve bioavailability or stability (1). The object of the study was to formulate and characterize Eudragit® Nanoparticles containing carvedilol by determining their size and zeta potential, their external morphology for the treatment of hypertension.